...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ... my letter forwarded to IR...

"....Lighten up, man!   I like your contributions, but sometimes you come across as sour...."

You definitely get extra points for being consistent.  Whenever common sense bumps into your factless distortions of reality, you respond with personal comments.

Share
New Message
Please login to post a reply